Skip to main content

Moderna’s stock tumbles to post-COVID lows after revenue outlook disappoints

13 كانون الثاني 2025
Moderna’s stock tumbles after a disappointing outlook for revenue and the need to accelerate its cost-cutting plan.

For more details: Click here